Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT05377931
  4. Details
NCT05377931 Clinical Trial

Ocular and Cardiac Effects of Battle Ground

COVID-19 Clinical Trial

Official title:
Ocular and Cardiac Effects of Mobile Battle Ground Games

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05377931
Other study ID # RC 10-22
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 10, 2022
Est. completion date February 20, 2023

Study information
Verified date May 2022
Source Benha University
Contact Ahmed Abdelshafy, MD
Phone 01222328766
Email ahmad4lg@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Mobile battle ground games are widely used in various age groups, there are ocular and cardiac affection that may affect users of this type of action games.

Description:

The aim of this study is to assess the possible ocular and cardiac changes that may affect users of this type of mobile games in real life among various age groups and especially in adults with history of recent corona virus (COVID-19) disease. There is no medical recommendations about the time and the hazards of using this games for longer periods in real practice.

Recruitment information / eligibility
Status Recruiting
Enrollment 150
Est. completion date February 20, 2023
Est. primary completion date February 10, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - Normal subjects that are playing or not playing action mobile battle ground games will be included. - Post COVID-19 subjects with average 6 months of infection and are playing mobile battle. Ground games will be included. Exclusion Criteria: - Subjects that refuse to enter the study. - Users of mobile battle ground games with other diseases that may affect ocular and cardiac assessment as diabetic eye disease, cardiac congenital anomalies or recent cardiac or ocular surgery.

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Changes in heart pulse rate
Measuring heart pulse rate using a wrest smart watch.
• Changes in eye strain
Changes in Accommodation measured by auto refractometer before and after mobile battle ground gaming.

Locations
Country Name City State
Egypt Ahmed Abdelshafy Banha QA

Sponsors (1)
Lead Sponsor Collaborator
Benha University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Changes in heart pulse rate Changes in pulse in each group members measured by smart wrest watch in pulse beat/per minute. During playing mobile battle ground games
Secondary Changes in accommodation Changes in eye accommodation measured by auto refractometer in diopter (D). Before and immediately after mobile battle ground games
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure